Company news

Insulet Corporation news in 2026

Insulet Corporation's news releases, calls and decks from 2026, newest first.

View company

Insulet Reports Third Quarter 2026 Results

November 4, 2026

Insulet to Participate in the 2026 Jefferies Global Healthcare Conference in London

November 3, 2026

Insulet Announces Omnipod Discover Now Available in U.S.

October 12, 2026

Insulet to Announce Third Quarter 2026 Financial Results on November 4, 2026

October 1, 2026

Insulet to Participate in Bernstein Insights: Healthcare Leaders and Disruptors – 3rd Annual Healthcare Forum

September 18, 2026

Insulet to Participate in Wells Fargo 21st Annual Healthcare Conference

August 26, 2026

Insulet Reports Second Quarter 2026 Results

August 5, 2026

Insulet Partners with Calm to Bring Mindfulness and Well-Being Tools to the Diabetes Community, Featuring a New Sleep Story Narrated by Lila Moss

July 14, 2026

Insulet Accelerates Global Growth with Launch of Omnipod(R) 5 and Omnipod Discover in Spain, Expanding Access to Tubeless Diabetes Technology

July 7, 2026

Insulet Accelerates Global Growth with Launch of Omnipod® 5 and Omnipod Discover™ in Spain, Expanding Access to Tubeless Diabetes Technology

July 6, 2026

Insulet to Announce Second Quarter 2026 Financial Results on August 5, 2026

July 1, 2026

Insulet Announces Appointment of Jonathan J. Mazelsky to its Board of Directors

June 25, 2026

Insulet Reveals New Data Supporting Breakthrough Omnipod® 6 and Fully Closed-Loop AID Systems Designed to Improve Outcomes, Reduce Effort, and Unlock Barriers to Care

June 6, 2026

Insulet to Spotlight New Data and Innovations Demonstrating How Omnipod® Simplifies Diabetes Management and Delivers Strong Clinical Outcomes at the American Diabetes Association 86th Scientific Sessions

June 4, 2026

Insulet Announces U.S. Rollout of Enhanced Omnipod® 5 Algorithm and Expands Compatibility with Abbott’s FreeStyle Libre 3 Plus Sensor

June 3, 2026

Insulet to Participate in William Blair 46th Annual Growth Stock Conference

May 27, 2026

Insulet Initiates Voluntary Medical Device Correction for Certain Omnipod® Pods in the U.S. and Affected International Markets

May 26, 2026

Insulet Reports First Quarter 2026 Results

May 6, 2026

Insulet Unveils 2025 Sustainability Report Highlighting Strong Momentum Across Key Priorities

May 5, 2026

Insulet Initiates EVOLVE Pivotal Study to Advance Fully Closed-Loop Automated Insulin Delivery System for Type 2 Diabetes

May 4, 2026

Insulet to Participate in BofA Securities 2026 Health Care Conference

April 28, 2026

Insulet to Announce First Quarter 2026 Financial Results on May 6, 2026

March 31, 2026

Insulet Appoints Mike Panos as Chief Commercial Officer

March 29, 2026

Insulet Initiates Voluntary Medical Device Correction for Certain Omnipod® 5 Pods in the U.S.

March 12, 2026

Insulet Presents Promising Study Results for Fully Closed-Loop Automated Insulin Delivery System for Adults with Type 2 Diabetes

March 10, 2026

Insulet to Present EVOLUTION 2 Results on Omnipod® Fully Closed-Loop System for Adults with Type 2 Diabetes at International Conference on Advanced Technologies & Treatments for Diabetes (ATTD)

March 9, 2026

Insulet Reports Fourth Quarter and Full Year 2025 Results

February 18, 2026

Insulin Pump Market Insights $2.1B Revenue from Insulet, 500,000+ U.S. Users and 47.8% Adoption in Canada Driven by Government Funding

February 6, 2026

Insulet Launches Omnipod® 5 and Omnipod Discover™ in the Middle East to Transform Diabetes Care

February 5, 2026

Insulet to Announce Fourth Quarter and Full Year 2025 Financial Results on February 18, 2026

January 9, 2026

Insulet Redefines Diabetes at CES with "Liveable Technology" — A New Frontier in Human-Centered Connected Health

January 6, 2026

Calls in 2026

Decks in 2026